MGTX earnings: next report 2026-08-13, real EPS beat/miss history, analyst consensus Buy, P/E -8.22. Updated 2026-07-23.
MeiraGTx Holdings (MGTX) Research Hub
MeiraGTx Holdings (MGTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 12.79 USD (-3.54%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -8.22, market cap 1.13B. This hub links to the full technical, earnings and options research available for MGTX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 12.79 USD (-3.54%) |
| 52-week range | 9.56 USD – 15.35 USD |
| Trend regime | Range |
| 14-day RSI | 47.9 (Neutral) |
| Trailing P/E | -8.22 |
| Market cap | 1.13B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for MGTX
Covered Call on MGTX: how it works, illustrative setup around the real 12.79 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MGTX: how it works, illustrative setup around the real 12.79 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MGTX: how it works, illustrative setup around the real 12.79 USD price, max profit/loss, breakeven and when to use it. Educational.
MGTX technical analysis: range, last 12.79 USD, RSI 47.9, 52w range 9.56 USD–15.35 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is MGTX in?
MeiraGTx Holdings (MGTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MGTX in an uptrend or downtrend?
As of 2026-09-11, MGTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MGTX's trailing P/E ratio?
MGTX's trailing P/E is -8.22, with a market cap of 1.13B. See the earnings research page for full valuation detail.
When does MGTX next report earnings?
MGTX is next scheduled to report earnings on 2026-08-13, with a consensus EPS estimate of -0.32857 USD.